Skip to main content
Fig. 5 | BMC Ophthalmology

Fig. 5

From: Intravitreal ranibizumab or conbercept for retinal arterial macroaneurysm: a case series

Fig. 5

Multimodal imaging of the affected eye in case 3. a. ICGA at the early phase showing hyperfluoresence at the infratemperal area of the edge of the dark area at the baseline visit. b. ICGA at the late phase showing the continuing lighting in the same area at the baseline visit. c. FA at the early phase showing fluorescein filling of the macroaneurysm at the 6-month follow-up. d. FA at the late phase showing not faded fluorescein filling of the macroaneurysm at the 6-month follow-up. e. OCT-A 6 mm × 6 mm superficial slab revealed the RAM at the 6-month follow-up. f. OCT-A 3 mm × 3 mm superficial slab clearly delineated the RAM at the 6-month follow-up. White arrow indicated the macroaneurysm

Back to article page